ESR1 and breast carcinoma: Breast carcinomas are highly heterogeneous diseases traditionally categorized into subgroups based on the immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).